September 9, 2020 Comments Off on Patent delisted for Taiho Oncology drug LONSURF Posted in: Uncategorized
Annual Drug Patent Expirations for LONSURF Lonsurf is a drug marketed by Taiho Oncology and is included in one NDA. It is available from one supplier. There are five patents…
The post Patent delisted for Taiho Oncology drug LONSURF appeared first on Dr…
September 9, 2020 Comments Off on Patent delisted for Merck Sharp drug PREVYMIS Posted in: Uncategorized
Annual Drug Patent Expirations for PREVYMIS Prevymis is a drug marketed by Merck Sharp Dohme and is included in two NDAs. It is available from one supplier. There are three…
The post Patent delisted for Merck Sharp drug PREVYMIS appeared first on DrugP…
